Financhill
Back

Pacific Biosciences of California Vs. Navidea Biopharmaceuticals Industry Stock Comparison

Sell
27

PACB
Pacific Biosciences of California

Last Price:
3.72
Seasonality Move:
-1.44%
Sell
14

NAVB
Navidea Biopharmaceuticals

Last Price:
0.04
Seasonality Move:
4.74%
Sell
27
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $3.72. The Score for PACB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Navidea Biopharmaceuticals (NAVB) is a Sell

Is Navidea Biopharmaceuticals a Buy, Sell or Hold?

  • The current Navidea Biopharmaceuticals [NAVB] share price is $0.04. The Score for NAVB is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • NAVB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $3.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight buying pressure.

NAVB Stock Price Chart

What is Navidea Biopharmaceuticals's stock price today?

  • The Navidea Biopharmaceuticals share price today is $0.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAVB is experiencing buying pressure, which is a positive indicator for future bullish movement.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 34.71 Sell
Chaikin Money Flow: 2309181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.7 - 5.08) Sell
Bollinger Bands (100): (5.03 - 8.81) Sell

NAVB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 44.45 Sell
Chaikin Money Flow: -56053 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.04 - 0.04) Sell
Bollinger Bands (100): (0.04 - 0.06) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.69 Buy
20-day SMA: 4.15 Sell
50-day SMA: 5.45 Sell
200-day SMA: 8.86 Sell
8-day EMA: 3.74 Sell
20-day EMA: 4.19 Sell
50-day EMA: 5.32 Sell
200-day EMA: 7.88 Sell

NAVB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.04 Sell
20-day SMA: 0.04 Sell
50-day SMA: 0.04 Sell
200-day SMA: 0.07 Sell
8-day EMA: 0.04 Sell
20-day EMA: 0.04 Sell
50-day EMA: 0.04 Sell
200-day EMA: 0.09 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.19 per share.

Navidea Biopharmaceuticals Earnings Growth & NAVB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Navidea Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):